abstract |
The present invention relates to benzo-fused heterocyclic derivatives, pharmaceutical compositions comprising said benzo-fused heterocyclic derivatives and their use in the treatment of disorders and conditions modulated by GPR120. More specifically, the compounds of the invention are agonists of GPR120, which are useful in the treatment of, such as, for example, type II diabetes. |